Patient Number Age (years) Sex Type of Lesion Site & Location Number of Lesions Size of Lesions *Prior Therapy
1 39 F Intransit Metastases Skin and subcutaneous Tissue: Thigh 10 3-10 mm Multiple excisions
2 79 M Intransit metastases Scalp Too many 2-3 mm BCG
3 52 F Intransit metastases Subcutaneous tissue: Leg& Thigh 13 5-10 mm Multiple excisions, HILP, LI, BCG
4 44 M Intransit metastases Subcutaneous tissue: Thigh 3 5-10 mm Multiple excisions, HILPx2 & RT
5 74 M Intransit metastases Skin and subcutaneous tissue: Shoulder Coalesced And scaly Large >30 mm Multiple excisions and BCG
6 51 M Intransit metastases Skin and subcutaneous tissue: Neck Coalesced forming soft tissue masses Large >50 mm Multiple excision and BCG
7 67 M Intransit metastases Scalp Coalesced forming soft tissue masses Large >50  mm Multiple excisions & RT
8 70 M Primary & satellite Skin: forearm 2 2-3 mm None
9 63 F Distant metastases Subcutaneous tissue: Supraclavicular 2 5-7 mm Systemic
10 50 F Distant metastases Subcutaneous tissue: axilla 3 5-10 mm None
*Prior therapy for the treated lesions, BCG: bacillus Calmette Guerin, HILP: hyperthermic isolated limb perfusion, LI: limb infusion, RT: radiation therapy
Table 1: Demographics of the Study Patients.